Activation of RyR2 by class I kinase inhibitors

Autores
Chakraborty, A. D.; Gonano, Luis Alberto; Munro, M. L.; Smith, L. J,; Thekkedam, C.; Staudacher, V.; Gamble, A. B.; Macquaide, N.; Dulhunty, A. F.; Jones, P. P.
Año de publicación
2019
Idioma
español castellano
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Kinase inhibitors are a common treatment for cancer. Class I kinase inhibitors that target the ATP-binding pocket are particularly prevalent. Many of these compounds are cardiotoxic and can cause arrhythmias. Spontaneous release of Ca2+ via cardiac ryanodine receptors (RyR2), through a process termed store overload-induced Ca2+ release (SOICR), is a common mechanism underlying arrhythmia. We explored whether class I kinase inhibitors could modify the activity of RyR2 and trigger SOICR to determine if this contributes to the cardiotoxic nature of these compounds.
Centro de Investigaciones Cardiovasculares
Materia
Ciencias Médicas
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by-nc-sa/4.0/
Repositorio
SEDICI (UNLP)
Institución
Universidad Nacional de La Plata
OAI Identificador
oai:sedici.unlp.edu.ar:10915/108114

id SEDICI_b21994f18d8d11781c227974983b851d
oai_identifier_str oai:sedici.unlp.edu.ar:10915/108114
network_acronym_str SEDICI
repository_id_str 1329
network_name_str SEDICI (UNLP)
spelling Activation of RyR2 by class I kinase inhibitorsChakraborty, A. D.Gonano, Luis AlbertoMunro, M. L.Smith, L. J,Thekkedam, C.Staudacher, V.Gamble, A. B.Macquaide, N.Dulhunty, A. F.Jones, P. P.Ciencias MédicasKinase inhibitors are a common treatment for cancer. Class I kinase inhibitors that target the ATP-binding pocket are particularly prevalent. Many of these compounds are cardiotoxic and can cause arrhythmias. Spontaneous release of Ca2+ via cardiac ryanodine receptors (RyR2), through a process termed store overload-induced Ca2+ release (SOICR), is a common mechanism underlying arrhythmia. We explored whether class I kinase inhibitors could modify the activity of RyR2 and trigger SOICR to determine if this contributes to the cardiotoxic nature of these compounds.Centro de Investigaciones Cardiovasculares2019info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf773-786http://sedici.unlp.edu.ar/handle/10915/108114spainfo:eu-repo/semantics/altIdentifier/url/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC6393232&blobtype=pdfinfo:eu-repo/semantics/altIdentifier/issn/0007-1188info:eu-repo/semantics/altIdentifier/pmid/30588601info:eu-repo/semantics/altIdentifier/doi/10.1111/bph.14562info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-sa/4.0/Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-10-15T11:15:46Zoai:sedici.unlp.edu.ar:10915/108114Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-10-15 11:15:46.926SEDICI (UNLP) - Universidad Nacional de La Platafalse
dc.title.none.fl_str_mv Activation of RyR2 by class I kinase inhibitors
title Activation of RyR2 by class I kinase inhibitors
spellingShingle Activation of RyR2 by class I kinase inhibitors
Chakraborty, A. D.
Ciencias Médicas
title_short Activation of RyR2 by class I kinase inhibitors
title_full Activation of RyR2 by class I kinase inhibitors
title_fullStr Activation of RyR2 by class I kinase inhibitors
title_full_unstemmed Activation of RyR2 by class I kinase inhibitors
title_sort Activation of RyR2 by class I kinase inhibitors
dc.creator.none.fl_str_mv Chakraborty, A. D.
Gonano, Luis Alberto
Munro, M. L.
Smith, L. J,
Thekkedam, C.
Staudacher, V.
Gamble, A. B.
Macquaide, N.
Dulhunty, A. F.
Jones, P. P.
author Chakraborty, A. D.
author_facet Chakraborty, A. D.
Gonano, Luis Alberto
Munro, M. L.
Smith, L. J,
Thekkedam, C.
Staudacher, V.
Gamble, A. B.
Macquaide, N.
Dulhunty, A. F.
Jones, P. P.
author_role author
author2 Gonano, Luis Alberto
Munro, M. L.
Smith, L. J,
Thekkedam, C.
Staudacher, V.
Gamble, A. B.
Macquaide, N.
Dulhunty, A. F.
Jones, P. P.
author2_role author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Ciencias Médicas
topic Ciencias Médicas
dc.description.none.fl_txt_mv Kinase inhibitors are a common treatment for cancer. Class I kinase inhibitors that target the ATP-binding pocket are particularly prevalent. Many of these compounds are cardiotoxic and can cause arrhythmias. Spontaneous release of Ca2+ via cardiac ryanodine receptors (RyR2), through a process termed store overload-induced Ca2+ release (SOICR), is a common mechanism underlying arrhythmia. We explored whether class I kinase inhibitors could modify the activity of RyR2 and trigger SOICR to determine if this contributes to the cardiotoxic nature of these compounds.
Centro de Investigaciones Cardiovasculares
description Kinase inhibitors are a common treatment for cancer. Class I kinase inhibitors that target the ATP-binding pocket are particularly prevalent. Many of these compounds are cardiotoxic and can cause arrhythmias. Spontaneous release of Ca2+ via cardiac ryanodine receptors (RyR2), through a process termed store overload-induced Ca2+ release (SOICR), is a common mechanism underlying arrhythmia. We explored whether class I kinase inhibitors could modify the activity of RyR2 and trigger SOICR to determine if this contributes to the cardiotoxic nature of these compounds.
publishDate 2019
dc.date.none.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Articulo
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://sedici.unlp.edu.ar/handle/10915/108114
url http://sedici.unlp.edu.ar/handle/10915/108114
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC6393232&blobtype=pdf
info:eu-repo/semantics/altIdentifier/issn/0007-1188
info:eu-repo/semantics/altIdentifier/pmid/30588601
info:eu-repo/semantics/altIdentifier/doi/10.1111/bph.14562
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc-sa/4.0/
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-sa/4.0/
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
dc.format.none.fl_str_mv application/pdf
773-786
dc.source.none.fl_str_mv reponame:SEDICI (UNLP)
instname:Universidad Nacional de La Plata
instacron:UNLP
reponame_str SEDICI (UNLP)
collection SEDICI (UNLP)
instname_str Universidad Nacional de La Plata
instacron_str UNLP
institution UNLP
repository.name.fl_str_mv SEDICI (UNLP) - Universidad Nacional de La Plata
repository.mail.fl_str_mv alira@sedici.unlp.edu.ar
_version_ 1846064215638409216
score 13.22299